178 related articles for article (PubMed ID: 22653756)
1. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients.
Hussein YM; Morad FE; Gameel MA; Emam WA; El Sawy WH; El Tarhouny SA; Bayomy ES; Raafat N
Med Oncol; 2012 Dec; 29(5):3055-62. PubMed ID: 22653756
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Ibrahim GH; Mahmoud MA; Aly NM
Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
[TBL] [Abstract][Full Text] [Related]
3. MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma.
Hussein YM; Ghareib AF; Mohamed RH; Radwan MI; Elsawy WH
Med Oncol; 2012 Jun; 29(2):994-9. PubMed ID: 21452042
[TBL] [Abstract][Full Text] [Related]
4. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
5. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
6. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
8. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Nomair AM; Kandil LS; Nomeir HM; Kandil NS
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
Farid IM; Hamza IM; El-Abd DM; Mohyi AM; AbdulLatif MM; Aref AT; Hamza DM
Arab J Gastroenterol; 2014; 15(3-4):142-7. PubMed ID: 25475758
[TBL] [Abstract][Full Text] [Related]
10. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
[TBL] [Abstract][Full Text] [Related]
11. A panel of molecular markers in hepatitis C virus-related hepatocellular carcinoma.
Elgendy SM; Hessien M; Elsherbiny MM; Abd El-Salam IM; El-Attar IA; El-Asser Ael-B
J Egypt Natl Canc Inst; 2005 Dec; 17(4):270-8. PubMed ID: 17102821
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.
Yamashita S; Kato A; Akatsuka T; Sawada T; Asai T; Koyama N; Okita K
World J Gastroenterol; 2020 Apr; 26(13):1463-1473. PubMed ID: 32308347
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.
Mou DC; Cai SL; Peng JR; Wang Y; Chen HS; Pang XW; Leng XS; Chen WF
Br J Cancer; 2002 Jan; 86(1):110-6. PubMed ID: 11857021
[TBL] [Abstract][Full Text] [Related]
14. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
15. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
Yan D; He Q; Chen Y; Wang L; Zhang X
J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients.
Zhao L; Mou DC; Peng JR; Huang L; Wu ZA; Leng XS
World J Gastroenterol; 2010 Aug; 16(32):4072-8. PubMed ID: 20731022
[TBL] [Abstract][Full Text] [Related]
17. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
18. Increased Serum Endoglin and Transforming Growth Factor β1 mRNA Expression and Risk of Hepatocellular Carcinoma in Cirrhotic Egyptian Patients.
Teama S; Fawzy A; Teama S; Helal A; Drwish AD; Elbaz T; Desouky E
Asian Pac J Cancer Prev; 2016; 17(5):2429-34. PubMed ID: 27268609
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study.
Toraih EA; Alrefai HG; Hussein MH; Helal GM; Khashana MS; Fawzy MS
Clin Biochem; 2019 Jan; 63():10-17. PubMed ID: 30521791
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
